ID3 and ovarian cancer: This could indicate that in PA-1 and ES-2 ovarian cancer cells, Id1/3-PA7 might preferentially inhibit the heterodimerisation of Id1 and Id3 with ETS proteins, which are the positive regulators of CDKN2A.